AMP and Molecular Diagnostics’ Existential Crisis

This special edition episode for the upcoming Association for Molecular Pathology (AMP) annual meeting in Vancouver, Jane Gibson, PhD, opens up the dialogue about how the evolving field of molecular pathology is taking on major challenges, including how the FDA’s ruling on laboratory developed tests (LDTs) is affecting clinical labs. Dr. Gibson is a Professor of Pathology at the University of Central Florida, Editor-in-chief of Genetic Testing and Molecular Biomarkers, and President Elect of AMP.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.

Produced by Bill Levine

Hosted by Jonathan D. Grinstein, PhD

Music provided by Artem Hramushkin

Audio mixed and mastered by Jason Mack

Hosted on Acast. See acast.com/privacy for more information.